Spyre Therapeutics, Inc. · NASDAQ:SYRE
BlackRock, Inc. reported a 6.60% stake in Spyre Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc. reported a 6.60% stake in Spyre Therapeutics, Inc., 3,962,635 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 6.60%
- Shares
- 3,962,635
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.60% | 3,962,635 |